NCT02482935View on ClinicalTrials.gov

A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

Abemaciclib

Administered orally

Trial Locations (2)

32117

Covance Clinical Research Unit, Daytona Beach

75247

Covance Clinical Research Unit, Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02482935 - A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food | Biotech Hunter | Biotech Hunter